EyePoint Pharmaceuticals, Inc. (EYPT) — Business segments and KPIs
Revenue by business segment and geography for EyePoint Pharmaceuticals, Inc., with year-over-year trends.
FY 2024
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| License And Collaboration Agreement | 38.50M | 83.0% |
| Product | 3.16M | 6.8% |
| Y U T I Q Product | 3.10M | 6.7% |
| Royalty | 1.61M | 3.5% |
| Revenue by region | ||
| UNITED STATES | 42.05M | 97.4% |
| CHINA | 1.12M | 2.6% |